Experimental Hyperleptinemia Acutely Increases Vasoconstrictory Sympathetic Nerve Activity in Healthy Humans
The DOI matches its Crossref record; 20 of the 39 references it cites were found in a registry or an index.
Abstract
Background Obesity and arterial hypertension are tightly connected. Obese individuals show significant elevation of vasoconstrictory muscle sympathetic nerve activity (MSNA). Obesity-related hyperleptinemia might play a key role in mediating these effects. Leptin is synthesized in proportion to body fat mass and activates SNA in animal models. In humans, however, direct evidence linking hyperleptinemia to sympathetic activation has not yet been established. In the present study, we characterize the effects of acute hyperleptinemia on microneurographically recorded SNA in humans. Methods In a balanced, double-blind crossover design, 12 healthy normal-weight males received an iv bolus of leptin or placebo. MSNA (bursts per minute) was continuously recorded using a microneurographic technique. Ten-minute periods were analyzed at resting periods before (t-100) and at 20 (t20), 60 (t60), and 140 (t140) minutes after substance administration. Blood pressure and heart rate (HR) were recorded simultaneously. Results Baseline values of MSNA, blood pressure, and HR were comparable in both conditions (MSNA: t-100, 24.3 ± 1.6 vs 22.7 ± 1.7, not significant). After application of leptin, MSNA showed a significant increase (t20, 31.0 ± 1.9 vs. 24.9 ± 1.8, P = .05) that persisted until the end of the experiment (t60, P = .008; t140, P = .004). There were no significant changes in blood pressure and HR. Conclusions Acute experimental hyperleptinemia has significant central nervous excitatory…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to findings in rodents, acute leptin administration stimulates SNA in humans132.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [132]
In the citing paper
“More recent studies indicate that acute hyperleptinemia increases MSNA in humans85.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [85]
In the citing paper
“Acute leptin administration in rodents and humans increases renal and muscle SNS activity [45, 46] while chronic increases in plasma leptin levels, comparable to those found in severe obesity, caused sustained increases in BP and HR in rodents despite causing weight loss which would normally reduce BP [47].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [46]
In the citing paper
“Machleidt et al93 demonstrated that a bolus injection of leptin in healthy lean men produced an acute increase in muscle sympathetic nerve activity but blood pressure did not increase.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [93]
In the citing paper
“They found that in young healthy man intravenous bolus administration of leptin caused a gradual increase in muscle sympathetic nerve activity that persisted for over 2 hours.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [45]
Citations
Cites
Receptor-mediated regional sympathetic nerve activation by leptin.
Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., & Sivitz, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119532 · Cited by 979
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Doll, S., Paccaud, F., Bovet, P., Burnier, M., & Wietlisbach, V (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801854 · Cited by 311
Renal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307
Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension
Grassi, G., Seravalle, G., Dell’Oro, R., Turri, C., Bolla, G. B., & Mancia, G. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.538 · Cited by 305
Lambert, E. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00052 · Cited by 244
Role of leptin in blood pressure regulation and arterial hypertension
Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 215
Sympathetic nervous system behavior in human obesity
Davy, K. P., & Orr, J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.024 · Cited by 166
Involvement of Nitric Oxide in Endothelium-Dependent Arterial Relaxation by Leptin
Kimura, K., Tsuda, K., Baba, A., Kawabe, T., Boh-oka, S.-I., Ibata, M., Moriwaki, C., Hano, T., & Nishio, I. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3005 · Cited by 159
Autonomic Contribution to Blood Pressure and Metabolism in Obesity
Shibao, C., Gamboa, A., Diedrich, A., Ertl, A. C., Chen, K. Y., Byrne, D. W., Farley, G., Paranjape, S. Y., Davis, S. N., & Biaggioni, I. (2007) · Hypertension · doi:10.1161/01.hyp.0000251679.87348.05 · Cited by 147
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure
Lambert, E., Straznicky, N., Eikelis, N., Esler, M., Dawood, T., Masuo, K., Schlaich, M., & Lambert, G. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281053af4 · Cited by 122
Relationship Between Muscle Sympathetic Nerve Activity and Plasma Leptin Concentration
Snitker, S., Pratley, R. E., Nicolson, M., Tataranni, P. A., & Ravussin, E. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00561.x · Cited by 110
Momin, A. U. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi831 · Cited by 97
Modest weight gain is associated with sympathetic neural activation in nonobese humans
Gentile, C. L., Orr, J. S., Davy, B. M., & Davy, K. P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00876.2006 · Cited by 92
Sympathetic Function in Human Carriers of Melanocortin-4 Receptor Gene Mutations
Sayk, F., Heutling, D., Dodt, C., Iwen, K. A., Wellhoner, J. P., Scherag, S., Hinney, A., Hebebrand, J., & Lehnert, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2297 · Cited by 86
Self-citationEndotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans
Sayk, F., Vietheer, A., Schaaf, B., Wellhoener, P., Weitz, G., Lehnert, H., & Dodt, C. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90444.2008 · Cited by 81
Self-citationJones, A., McMillan, M. R., Jones, R. W., Kowalik, G. T., Steeden, J. A., Deanfield, J. E., Pruessner, J. C., Taylor, A. M., & Muthurangu, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039143 · Cited by 71
Modulation of blood pressure by central melanocortinergic pathways
Maier, T., & Hoyer, J. D. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp644 · Cited by 27
Cited by
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 368
Metadata
- Authors
- Machleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., & Sayk, F.
- Affiliations
- University Hospital Schleswig-Holstein (DE)
- University of Tübingen (DE)
- Corresponding author
- Sayk, Friedhelm
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-03-01
- Volume
- 98
- Issue
- 3
- Pages
- E491-E496
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105572243
- Cited by
- 61
- References
- 39
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 2
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- leptin, hyperleptinemia, muscle sympathetic nerve activity, vasoconstriction, sympathetic nervous system, obesity, hypertension, blood pressure, heart rate, microneurography, central nervous system stimulation
- MeSH terms
- Acute Disease, Adult, Blood Pressure, Double-Blind Method, Heart Rate, Humans, Hypertension, Injections, Intravenous, Male, Obesity, Pressoreceptors, Sympathetic Nervous System, Vasoconstriction, Muscle, Skeletal, Cross-Over Studies, Leptin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.